Skip to content
value.today

Glympse Bio, Inc.

Total raised
$91 M
3 rounds on record
Latest round
$18 M
Dec 2021
First round on record
Jul 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Glympse Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$23 MIssued in a merger or acquisition$10 to $50 million

Glympse Bio, Inc.: Private sale, Apr 2023

Investors in this round

10 investors had bought by the notice of May 12, 2023: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexandra Cantley · Director
  • Huilin Shao · Director
  • John Mcdonough · Director
  • Stanley Lapidus · Director
  • Steve Kafka · Director
  • Yingmin Wang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Mcdonough, Director. Source: SEC Form D, newest notice filed May 12, 2023. Read the notice at the SEC.

equitySEC
Dec 2021$18 MNo. 3$10 to $50 million

Glympse Bio, Inc.: Raise no. 3, Dec 2021

Investors in this round

12 investors had bought by the notice of Dec 17, 2021: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Caroline Loew · Executive Officer, Director
  • Dhaval Winckler Gosalia · Executive Officer
  • Jessica Winckler Atkinson · Executive Officer
  • Matthew Winckler Navarro · Executive Officer
  • Tram Winckler Tran · Executive Officer
  • Wendy Winckler Adamovich · Executive Officer
  • Amy Schulman · Director
  • Francis Cuss · Director
  • George Zachary · Director
  • Robert Langer · Director
  • Stanley Lapidus · Director
  • Steve Kafka · Director
  • Theresia Gouw · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Caroline J. Loew, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 17, 2021. Read the notice at the SEC.

equitySEC
May 2020$47 MNo. 2$10 to $50 million

Glympse Bio, Inc.: Raise no. 2, May 2020

Investors in this round

19 investors had bought by the notice of Jul 1, 2021: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$47 M of $47 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Caroline Loew · Executive Officer, Director
  • Dhaval Winckler Gosalia · Executive Officer
  • Jessica Winckler Atkinson · Executive Officer
  • Wendy Winckler Adamovich · Executive Officer
  • Amy Schulman · Director
  • Francis Cuss · Director
  • George Zachary · Director
  • Robert Langer · Director
  • Stanley Lapidus · Director
  • Steve Kafka · Director
  • Theresia Gouw · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Caroline J. Loew, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 1, 2021. Read the notice at the SEC.

equitySEC
Jul 2018$26 MNo. 1$10 to $50 million

Glympse Bio, Inc.: Raise no. 1, Jul 2018

Investors in this round

17 investors had bought by the notice of Aug 6, 2018: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $30 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$900,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gabriel Kwong · Executive Officer
  • Sirshendu Roopom Banerjee · Executive Officer
  • Amy Roopom Schulman · Director
  • Stan Roopom Lapidus · Director
  • Theresia Roopom Guow · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The issuer anticipates that it will use a portion of the proceeds of the offering to pay compensation, which is currently expected to be approximately $900,000 per year in the aggregate, for certain of the individuals named in item 3 above.”

Signed by Sirshendu Roopom Banerjee, Chief Business Officer. Source: SEC Form D, newest notice filed Aug 6, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Glympse Bio, Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2023

That is all the official record says: Glympse Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Glympse Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Glympse Bio, Inc.
NameRoleNamed in
Caroline LoewExecutive officerDec 2021
Dhaval Winckler GosaliaExecutive officerDec 2021
Jessica Winckler AtkinsonExecutive officerDec 2021
Matthew Winckler NavarroExecutive officerDec 2021
Tram Winckler TranExecutive officerDec 2021
Wendy Winckler AdamovichExecutive officerDec 2021
Tracey DawsonExecutive officerJun 2020
Gabriel KwongExecutive officerAug 2018
Sirshendu Roopom BanerjeeExecutive officerAug 2018
Alexandra CantleyDirectorMay 2023
Huilin ShaoDirectorMay 2023
John McdonoughDirectorMay 2023
Stanley LapidusDirectorMay 2023
Steve KafkaDirectorMay 2023
Yingmin WangDirectorMay 2023
Amy SchulmanDirectorDec 2021
Caroline LoewDirectorDec 2021
Francis CussDirectorDec 2021
George ZacharyDirectorDec 2021
Robert LangerDirectorDec 2021
Theresia GouwDirectorDec 2021
Amy Roopom SchulmanDirectorAug 2018
Stan Roopom LapidusDirectorAug 2018
Theresia Roopom GuowDirectorAug 2018